or Try an Advanced Search...

    Technical Analysis for HCWB - HCW Biologics Inc.

    Grade Last Price % Change Price Change
    F 0.65 0.46% 0.00
    HCWB closed up 0.46 percent on Monday, July 1, 2024, on 59 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical HCWB trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Calm After Storm Range Contraction 0.46%
    NR7 Range Contraction 0.46%
    Narrow Range Bar Range Contraction 0.46%
    Lower Bollinger Band Walk Weakness 0.46%
    Inside Day Range Contraction 0.46%
    Wide Bands Range Expansion 0.46%
    Older End-of-Day Signals for HCWB ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 10 hours ago
    Down 2 % about 10 hours ago
    Down 1% about 10 hours ago
    60 Minute Opening Range Breakdown 3 days ago
    Rose Above Lower Bollinger Band 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    HCWB Chart by TradingView
    Basic chart:

    Profile

    HCW Biologics Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation and age-related diseases. The company is involved in developing HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. It is also developing HCW9218 as an injectable immunotherapeutic for patients with pancreatic, breast, ovarian, colorectal, and prostate cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata. The company was incorporated in 2018 and is headquartered in Miramar, Florida.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Clinical Medicine Acute Myeloid Leukemia Immunotherapies Prostate Cancer Leukemia Pulmonary Fibrosis Oncogenes Treatment Of Acute Myeloid Leukemia Age Related Diseases Alopecia Areata

    Is HCWB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 15 HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights
    Apr 1 HCW Biologics GAAP EPS of -$0.15, revenue of $1.3M
    Apr 1 HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights
    Jan 25 Several Insiders Invested In HCW Biologics Flagging Positive News
    See more HCWB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.32
    52 Week Low 0.6109
    Average Volume 23,949
    200-Day Moving Average 1.37
    50-Day Moving Average 1.13
    20-Day Moving Average 0.94
    10-Day Moving Average 0.80
    Average True Range 0.12
    RSI (14) 22.48
    ADX 19.54
    +DI 17.71
    -DI 25.34
    Chandelier Exit (Long, 3 ATRs) 0.86
    Chandelier Exit (Short, 3 ATRs) 0.97
    Upper Bollinger Bands 1.28
    Lower Bollinger Band 0.59
    Percent B (%b) 0.08
    BandWidth 73.54
    MACD Line -0.13
    MACD Signal Line -0.10
    MACD Histogram -0.0306
    Fundamentals Value
    Market Cap 23.38 Million
    Num Shares 36 Million
    EPS -0.56
    Price-to-Earnings (P/E) Ratio -1.16
    Price-to-Sales 14.85
    Price-to-Book 1.69
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.87
    Resistance 3 (R3) 0.88 0.83 0.83
    Resistance 2 (R2) 0.83 0.77 0.82 0.82
    Resistance 1 (R1) 0.74 0.74 0.78 0.72 0.81
    Pivot Point 0.68 0.68 0.70 0.67 0.68
    Support 1 (S1) 0.59 0.63 0.64 0.58 0.49
    Support 2 (S2) 0.54 0.59 0.53 0.48
    Support 3 (S3) 0.45 0.54 0.47
    Support 4 (S4) 0.43